TABLE 3.
MICs of β-lactam antibiotics for MRSA clinical isolatesa
Isolate | MIC (μg/ml) of:
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Oxacillin
|
Floxacillin
|
Cephalothin
|
Cefoxitin
|
Cefoperazone
|
||||||
Control sample | ODN833-treated sample | Control sample | ODN833-treated sample | Control sample | ODN833-treated sample | Control sample | ODN833-treated sample | Control sample | ODN833-treated sample | |
071001 | 128 | 2 | 1,024 | 2 | 512 | 2 | 32 | 2 | 128 | 8 |
071002 | >1,024 | 2 | >1,024 | 2 | 512 | 8 | 512 | 1 | 1,024 | 2 |
071003 | >1,024 | 2 | >1,024 | 2 | 512 | 2 | 512 | 1 | 1,024 | 4 |
071004 | >1,024 | 1 | >1,024 | 2 | 512 | 8 | 512 | 4 | 1,024 | 4 |
MICs of β-lactam antibiotics in the presence and absence of anti-mecA PS-ODN833 encapsulated in anionic liposomes for four clinically isolated MRSA strains in broth cultures were determined. The concentration of liposome-encapsulated anti-mecA PS-ODN833 was 18 μM. The classification of S. aureus strains by MICs is as follows. Oxacillin MIC: ≤2 μg/ml, sensitive; ≥4 μg/ml, resistant. Floxacillin MIC: ≤2 μg/ml, sensitive; ≥4 μg/ml, resistant. Cephalothin MIC: ≤8 μg/ml, sensitive; 16 μg/ml, intermediate; ≥32 μg/ml, resistant. Cefoxitin MIC: ≤8 μg/ml, sensitive; 16 μg/ml, intermediate; ≥32 μg/ml, resistant. Cefoperazone MIC: ≤16 μg/ml, sensitive; 32 μg/ml, intermediate; ≥64 μg/ml, resistant.